ARCHIVES

Navelbine+Herceptin: 78% Response In Breast Cancer

This article is from The Cancer Letter archive.

Vol. 25 No. 11 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

Six More CCOPS In Funding Range For Recompetition

February 9, 1990

In Brief: New NIH Grant Program Offers Up To $1 Million a Year For Centers At Minority Institutions

January 25, 1985

In Brief: Former ICCCR Staff Form International Marketing Firm; M.D. Andersons Names New Professorship

October 2, 1992

BRCA Mutations In About 2% Of Breast Cancer Patients

August 25, 2006

Sebelius: Congress Harming Nation’s Investment in Science

October 4, 2013

Oxaliplatin Regimens Extend Survival Of Advanced Colorectal Cancer, Study Finds

June 27, 2003